Novel chemotherapeutic agents in early clinical development.
Stagg
M P
MP
University of Alabama, Birmingham.
Diasio
R B
RB
D000225:Adenine; D000470:Alkaloids / Q000627:therapeutic use; D000880:Anthraquinones / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use; D002166:Camptothecin / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007094:Imides; D000077146:Irinotecan; D007546:Isoquinolines / Q000627:therapeutic use; D053644:Naphthalimides; D009369:Neoplasms / Q000188:drug therapy*; D063065:Organophosphonates; D017239:Paclitaxel; D011720:Pyrazoles / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D013729:Terpenes / Q000627:therapeutic use; D016597:Trimetrexate; D011798:Quinaldines
D000225:Adenine; D000470:Alkaloids; D000880:Anthraquinones; D000970:Antineoplastic Agents; D001713:Biphenyl Compounds; D002166:Camptothecin; D007094:Imides; D000077146:Irinotecan; D007546:Isoquinolines; D053644:Naphthalimides; D063065:Organophosphonates; D017239:Paclitaxel; D011720:Pyrazoles; D011799:Quinazolines; D013453:Sulfonylurea Compounds; D013729:Terpenes; D016597:Trimetrexate; C037020:amonafide; C046943:brequinar; D011798:Quinaldines; C001470:4-ipomeanol; C046659:piroxantrone; C058179:sulofenur